Re: Hughes et al.: Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with juvenile idiopathic arthritis (Ophthalmology. 2019;126:415-424)

Sue Lightman; Rachael Niederer; Srilakshmi Sharma; Claire Hooper; Oren Tomkins-Netzer; Michal Kramer; Erika Marie Damato; Beatrice Peebo; Peter McCluskey

doi:10.1016/j.ophtha.2018.12.004

Re: Hughes et al.: Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with juvenile idiopathic arthritis (Ophthalmology. 2019;126:415-424)

Sue Lightman, Rachael Niederer, Srilakshmi Sharma, Claire Hooper, Oren Tomkins-Netzer^*, Michal Kramer, Erika Marie Damato, Beatrice Peebo, Peter McCluskey

^*Corresponding author for this work

Clinical Departments

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	e22-e24
Journal	Ophthalmology
Volume	126
Issue number	3
DOIs	https://doi.org/10.1016/j.ophtha.2018.12.004
State	Published - Mar 2019

Access to Document

10.1016/j.ophtha.2018.12.004

Cite this

Lightman, S., Niederer, R., Sharma, S., Hooper, C., Tomkins-Netzer, O., Kramer, M., Damato, E. M., Peebo, B., & McCluskey, P. (2019). Re: Hughes et al.: Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with juvenile idiopathic arthritis (Ophthalmology. 2019;126:415-424). Ophthalmology, 126(3), e22-e24. https://doi.org/10.1016/j.ophtha.2018.12.004

@article{a102ff665ae34cf0beb4197fe74a227a,

title = "Re: Hughes et al.: Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with juvenile idiopathic arthritis (Ophthalmology. 2019;126:415-424)",

author = "Sue Lightman and Rachael Niederer and Srilakshmi Sharma and Claire Hooper and Oren Tomkins-Netzer and Michal Kramer and Damato, {Erika Marie} and Beatrice Peebo and Peter McCluskey",

year = "2019",

month = mar,

doi = "10.1016/j.ophtha.2018.12.004",

language = "אנגלית",

volume = "126",

pages = "e22--e24",

journal = "Ophthalmology",

issn = "0161-6420",

publisher = "Elsevier Inc.",

number = "3",

}

Lightman, S, Niederer, R, Sharma, S, Hooper, C, Tomkins-Netzer, O, Kramer, M, Damato, EM, Peebo, B & McCluskey, P 2019, 'Re: Hughes et al.: Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with juvenile idiopathic arthritis (Ophthalmology. 2019;126:415-424)', Ophthalmology, vol. 126, no. 3, pp. e22-e24. https://doi.org/10.1016/j.ophtha.2018.12.004

TY - JOUR

T1 - Re

T2 - Hughes et al.: Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with juvenile idiopathic arthritis (Ophthalmology. 2019;126:415-424)

AU - Lightman, Sue

AU - Niederer, Rachael

AU - Sharma, Srilakshmi

AU - Hooper, Claire

AU - Tomkins-Netzer, Oren

AU - Kramer, Michal

AU - Damato, Erika Marie

AU - Peebo, Beatrice

AU - McCluskey, Peter

PY - 2019/3

Y1 - 2019/3

UR - http://www.scopus.com/inward/record.url?scp=85061544039&partnerID=8YFLogxK

U2 - 10.1016/j.ophtha.2018.12.004

DO - 10.1016/j.ophtha.2018.12.004

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 30803528

AN - SCOPUS:85061544039

SN - 0161-6420

VL - 126

SP - e22-e24

JO - Ophthalmology

JF - Ophthalmology

IS - 3

ER -

Re: Hughes et al.: Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with juvenile idiopathic arthritis (Ophthalmology. 2019;126:415-424)

Access to Document

Other files and links

Cite this